Study Results: CartiHeal Agili-C vs. Microfracture and Debridement

CartiHeal Agili-C Implant

CartiHeal announced two-year results of a pivotal Investigational Device Exemption study (IDE). The study was conducted to test the potential superiority of the Agili-C™ implant vs. microfracture and debridement for the treatment of joint surface lesions, chondral and osteochondral defects, in the knee joint. The IDE study is a multicenter, 2:1...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us